Search Results

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)

• Authors : Aymon, Romain Victor Rudolf; Mongin, Denis; Bergstra, Sytske Anne

Subjects: info:eu-repo/classification/ddc/616; Antirheumatic Agents; Arthritis

• Source: ISSN: 0003-4967 ; Annals of the rheumatic diseases, vol. 83, no. 4 (2024) p. 421-428.

Record details

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)

• Authors : Aymon, Romain; Mongin, Denis; Bergstra, Sytske Anne

Subjects: Antirheumatic Agents/therapeutic use; Arthritis; Rheumatoid/drug therapy

• Source: Aymon , R , Mongin , D , Bergstra , S A , Choquette , D , Codreanu , C , De Cock , D , Dreyer , L , Elkayam , O , Huschek , D , Hyrich , K L , Iannone , F , Inanc , N , Kearsley-Fleet , L , Koca , S S

Record details

Incidence of septic arthritis in patients with ankylosing spondylitis and seropositive rheumatoid arthritis following TNF inhibitor therapy

• Authors : Hyung Woo Kim; Minkyung Han; Inkyung Jung

Subjects: Adalimumab / therapeutic use; Antibodies; Monoclonal

Record details

Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy

• Authors : Dunvald, Ann Cathrine Dalgård; Søltoft, Kasper; Sheetal, Ekta

Subjects: Drug-disease-drug interactions; IL-6 receptor antagonist; Inflammation

• Source: Dunvald , A C D , Søltoft , K , Sheetal , E , Just , S A , Frederiksen , I E B , Nielsen , F , Olsen , D A , Madsen , J S , Hendricks , O & Stage , T B 2023 , ' Cytochrome P450 activity in

Record details

Effect of a 12-week high-intensity exercise intervention:a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis - study protocol for a randomised controlled trial

• Authors : Jønck, Simon; Adamsen, Malte Lund; Højgaard, Pil

Subjects: Antirheumatic Agents/therapeutic use; Arthritis; Rheumatoid/drug therapy

• Source: Jønck , S , Adamsen , M L , Højgaard , P , Rasmussen , I E , Ellingsgaard , H , Lund , M A V , Jørgensen , P G , Jacobsen , S , Køber , L , Vejlstrup , N , Dreyer , L , Pedersen , B K , Berg , R M

Record details

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: A systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis

• Authors : Roodenrijs, Nadia M.T.; Hamar, Attila; Kedves, Melinda ...

Subjects: arthritis; biological therapy; occupational therapy

Record details

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis:a systematic review and economic evaluation

• Authors : Tikhonova, Irina A; Yang, Huiqin; Bello, Segun

Subjects: Arthritis; Rheumatoid/drug therapy; Controlled Clinical Trials as Topic

• Source: Tikhonova , I A , Yang , H , Bello , S , Salmon , A , Robinson , S , Hemami , M R , Dodman , S , Kharechko , A , Haigh , R C , Jani , M , Mcdonald , T J & Hoyle , M 2021 , ' Enzyme-linked

Record details

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

• Authors : Josef S Smolen; Robert B M Landewé; Johannes W J Bijlsma ...

Subjects: rheumatoid arthritis; Synthetic Drugs; DMARDs (biologic)

• Source: Annals of the Rheumatic Diseases, 79, 6, pp. 685-699Smolen, J S, Landewé, R B M, Bijlsma, J W J, Burmester, G R, Dougados, M, Kerschbaumer, A, McInnes, I B, Sepriano, A, Van Vollenhoven, R F,

Record details

Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT

• Authors : Sue Pavitt; Christopher McCabe; Claire Davies

Subjects: Male; Cost-Benefit Analysis; Health Status

• Source: Brown, S, Everett, C C, Naraghi, K, Davies, C, Dawkins, B, Hulme, C, McCabe, C, Pavitt, S, Emery, P, Sharples, L & Buch, M H 2018, ' Alternative tumour necrosis factor inhibitors (TNFi) or abatacept

Record details

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

• Authors : João Eurico Fonseca; Vibeke Andersen; Miguel Ángel López Nevot ...

Subjects: 0301 basic medicine; Oncology; Male

• Source: Canet, L M, Sánchez-Maldonado, J M, Cáliz, R, Ramos, A R, Lupiañez, C B, Canhão, H, Martínez-Bueno, M, Escudero, A, Segura-Catena, J, Sorensen, S B, Hetland, M L, Soto-Pino, M J, Ferrer, M A,

Record details